PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 10, 2026Molecules0 citationsOpen Access

Structure–Activity Relationships of Hemocompatible Cationic 6-Azaindole Pyridinium Salts: Antimicrobial and Anticancer Activity

RCRoxana CiorteanuIMIoana C. MarinasCCCatalina Ionica Ciobanu

Key Points

  • The aim is to evaluate the antimicrobial and anticancer properties of synthesized 6-azaindole pyridinium salts and their hemocompatibility.
  • Synthesis and structural characterization of 6-azaindole pyridinium derivatives.
  • Evaluation of antimicrobial activity against Staphylococcus aureus, Escherichia coli, and Candida albicans.
  • Assessment of anticancer activity using the NCI 60 panel.
  • Hemocompatibility testing using a hemolytic index.
  • In silico estimation of ADME properties.
  • Compounds 2b and 2c demonstrated strong antimicrobial effects, particularly against Gram-positive bacteria.
  • Compound 2b showed 57% growth inhibition against the MDA-MB-468 breast cancer cell line at 10 mM.
  • Para-substitution of the phenyl ring with halogen or methoxy groups enhanced antimicrobial activity and selectivity.

Abstract

A series of 6-azaindole pyridinium derivatives were synthesized, structurally characterized, and evaluated for their antimicrobial (against Staphylococcus aureus, Escherichia coli, and Candida albicans) and anticancer properties (against NCI 60 panel). Hemocompatibility was evaluated using the hemolytic index, while ADME properties were estimated using in silico methods. Structure–activity relationship analysis indicated that para-substitution of the phenyl ring, particularly with halogen or methoxy groups, influences antimicrobial activity, selectivity toward Gram-positive bacteria, and hemocompatibility. Compounds 2b and 2c showed the most notable antimicrobial effects, including inhibition of microbial adhesion at hemocompatible concentrations. Compound 2b exhibited growth inhibition against cancer cells, showing 57% percent growth inhibition (PGI) against the MDA-MB-468 breast cancer cell line at 10 mM. Overall, these results highlight 6-azaindole pyridinium salts as a promising class of compounds for further investigation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ciorteanu et al. (2026) studied this question.

synapsesocial.com/papers/69d893eb6c1944d70ce04ed5https://doi.org/10.3390/molecules31071220
Ask AI
Helpful
Bookmark
Share
View Full Paper